| Advancing the global public health agenda for NAFLD: a consensus statement JV Lazarus, HE Mark, QM Anstee, JP Arab, RL Batterham, L Castera, ... Nature Reviews Gastroenterology & Hepatology 19 (1), 60-78, 2022 | 433 | 2022 |
| Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States ZM Younossi, M Stepanova, J Ong, G Trimble, S AlQahtani, I Younossi, ... Clinical Gastroenterology and Hepatology 19 (3), 580-589. e5, 2021 | 342 | 2021 |
| Liver injury in COVID-19: The current evidence SA Alqahtani, JM Schattenberg United European gastroenterology journal 8 (5), 509-519, 2020 | 293 | 2020 |
| Cirrhotic cardiomyopathy SA Alqahtani, TR Fouad, SS Lee Seminars in liver disease 28 (01), 059-069, 2008 | 255 | 2008 |
| Evaluation of abnormal liver tests. TA Woreta, SA Alqahtani The Medical Clinics of North America 98 (1), 1-16, 2013 | 253 | 2013 |
| Whole-genome sequencing reveals host factors underlying critical COVID-19 A Kousathanas, E Pairo-Castineira, K Rawlik, A Stuckey, CA Odhams, ... Nature 607 (7917), 97-103, 2022 | 222 | 2022 |
| Obesity in Saudi Arabia in 2020: prevalence, distribution, and its current association with various health conditions NA Althumiri, MH Basyouni, N AlMousa, MF AlJuwaysim, RA Almubark, ... Healthcare 9 (3), 311, 2021 | 167 | 2021 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 164 | 2022 |
| Clinical characteristics and predictors of 28-day mortality in 352 critically ill patients with COVID-19: a retrospective study A Alharthy, W Aletreby, F Faqihi, A Balhamar, F Alaklobi, K Alanezi, ... Journal of epidemiology and global health 11 (1), 98-104, 2021 | 139 | 2021 |
| Prevalence and predictors of anxiety among healthcare workers in Saudi Arabia during the COVID-19 pandemic SAA Thamer H. Alenazi, Nasser F. BinDhim, Meteb H. Alenazi, Hani Tamim, Reem ... Journal of Infection and Public Health, 2020 | 126 | 2020 |
| Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: Data from Global Burden of Disease 2009-2019 P Golabi, JM Paik, S AlQahtani, Y Younossi, G Tuncer, ZM Younossi Journal of hepatology 75 (4), 795-809, 2021 | 116 | 2021 |
| Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study TM Welzel, DR Nelson, G Morelli, A Di Bisceglie, RK Reddy, A Kuo, ... Gut 66 (10), 1844-1852, 2017 | 106 | 2017 |
| Safety and tolerability of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic hepatitis C virus genotype 1 infection: Analysis of phase III ION trials SA Alqahtani, N Afdhal, S Zeuzem, SC Gordon, A Mangia, P Kwo, M Fried, ... Hepatology 62 (1), 25-30, 2015 | 104 | 2015 |
| Update in liver transplantation SA Alqahtani Current opinion in gastroenterology 28 (3), 230-238, 2012 | 95 | 2012 |
| A narrative review of coronavirus disease 2019 (COVID-19): clinical, epidemiological characteristics, and systemic manifestations A Krishnan, JP Hamilton, SA Alqahtani, T A. Woreta Internal and emergency medicine 16, 815-830, 2021 | 88 | 2021 |
| Launching COVID-19 vaccination in Saudi Arabia: Lessons learned, and the way forward A Assiri, JA Al-Tawfiq, M Alkhalifa, H Al Duhailan, S Al Qahtani, ... Travel Medicine and Infectious Disease 43, 102119, 2021 | 83 | 2021 |
| COVID-19: An overview and a clinical update A Krishnan, JP Hamilton, SA Alqahtani, TA Woreta World journal of clinical cases 9 (1), 8, 2021 | 81 | 2021 |
| COVID-19 vaccine acceptance among health care workers in the Kingdom of Saudi Arabia JA Elharake, B Galal, SA Alqahtani, RF Kattan, MA Barry, MH Temsah, ... International Journal of Infectious Diseases 109, 286-293, 2021 | 78 | 2021 |
| Therapeutic plasma exchange in patients with life-threatening COVID-19: a randomised controlled clinical trial F Faqihi, A Alharthy, S Abdulaziz, A Balhamar, A Alomari, Z AlAseri, ... International journal of antimicrobial agents 57 (5), 106334, 2021 | 77 | 2021 |
| Continuous renal replacement therapy with the addition of CytoSorb cartridge in critically ill patients with COVID‐19 plus acute kidney injury: a case‐series A Alharthy, F Faqihi, ZA Memish, A Balhamar, N Nasim, A Shahzad, ... Artificial organs 45 (5), E101-E112, 2021 | 77 | 2021 |
Janus OngAssociate Professor, University of the Philippines College of MedicineEmail verificata su up.edu.ph
